On the Move (Company Changes and Promotions) (3/07)
Executive Summary
Who went where? In Vivo notes significant recent job changes at medical product companies and other firms in the life sciences industries.
Company Changes
BINDER, Jeffrey R.
To:Biomet Inc., Pres. & CEO (Feb.)
From:Abbott Laboratories Inc., SVP, Diagnostic Operations
Tel:574-267-6639
BOYER, Paul
To:AgION Technologies Inc., CFO (Feb.)
From:Silicore Inc., CFO & VP, New Market Dev.
Tel:781-224-7100
BRADLEY, Edward C.
To:VioQuest Pharmaceuticals Inc., CSO (Feb.)
From:Berlex Laboratories, CMO
Tel:732-274-0399
BROWN, Jade R.
To:Xencor Inc., VP, Bus. Dev. (Feb.)
From:Cell Therapeutics Inc., Chief Business Officer
Tel:626-305-5900
CALMAN, Sandra G.
To:Isolagen Inc., VP, CMO (Feb.)
From:Merck KGAA Dey, VP, Med. Affairs & Clin. Research & CMO
Tel:484-713-6000
CAPONE, Walter M.
To:Progenics Pharmaceuticals, VP, Commercial Dev. & Operations (Jan.)
From:Trimeris Inc., SVP, Commercial Operations
Tel:914-789-2800
CARTER, Eric G.
To:King Pharmaceuticals Inc., CSO (Feb.)
From:GlaxoSmithKline PLC, VP & Global Head, Clin. Dev. & Med. Affairs, Gastroenterology
Tel:423-989-8000
DARPÖ, Börje
To:Medivir AB, VP, Pharmaceutical Dev. (Feb.)
From:Daiichi Medical Research, VP & Head of Global Medicine
Tel:+468 5468 3100
DE POTOCKI, Paul
To:Aerocrine AB, Pres. & CEO (Feb.)
From:Biovitrum AB, SVP, Commercial & Strategic Dev.
Tel:540-633-7978
ELDRIDGE, George
To:Targanta Therapeutics Inc., CFO (Feb.)
From:Therion Biologics, CFO
Tel:514-332-1008
ELSON, Bob
To:Eclipsys Corp., CMO (Feb.)
From:Clinical Systems Design LLC, Founder
Tel:561-322-4321
GERMANN, Tim
To:Metabolon Inc., VP, Sales (Jan.)
From:US Genomics, Sales & Mktg.
Tel:919-572-1711
GERTSCH, Martin
To:ESBATech AG, CFO (Feb.)
From:Santhera Pharmaceuticals Holding, Audit Committee Chmn., BOD
Tel:+44 733 4900
GIALLORENZO, Peter
To:Interpharm Holdings Inc., CFO (Feb.)
From:Nice-Pak Products Inc., CFO
Tel:631-543-2800
HEINO, Mary Anne
To:Labopharm Inc., VP, Sales & Mktg. & Pres., Labopharm USA (Feb.)
From:Centocor Inc., VP, Sales
Tel:450-686-1017
LYNCH, Daniel S.
To:Ivrea Pharmaceuticals Inc., Pres. & CEO (Feb.)
From:ImClone Systems Inc., former CEO
Tel:617-376-2491
MCCREEDY, Bruce, PhD
To:Metabolon Inc., VP, Strategic Dev. (Jan.)
From:Fulcrum Pharma Developments, Former CEO
Tel:919-572-1711
MOHAMMED, Mansoor, PhD
To:CombiMatrix Molecular Diagnostics, Pres. & CEO (Feb.)
From:Quest Diagnostics Inc., Dir., Advanced Genomics
Tel:425-493-2000
MYINT, Steven
To:BTG PLC, CMO (Feb.)
From:University of Surrey, UK, Dean of Medicine & Prof., Medicine & Microbiology
Tel:+44 20 7575 0000
NORTHUP, Edward
To:Mentor Corp., VP, COO (Feb.)
From:Boston Scientific Corp., Pres., Pain Management
Tel:805-879-6000
NYGAARD, Geert Walther
To:Eigenomics AG, CEO (Feb.)
From:Abbott GMBH & Co. KG, Commercial Head, Diagnostic Div.
Tel:+49 024 3450
OSBALDESTON, Stephen J.
To:Ophthonix Inc., CEO (Feb.)
From:Ciba Vision, Pres. Global Specialty Lens & Lens Care
Tel:877-367-4966
PERRY, Gregory D.
To:Elixir Pharmaceuticals Inc., CFO (Jan.)
From:Domantis Ltd., CFO
Tel:617-995-7000
RADDING, Jeffrey, PhD
To:Epitome Biosystems, VP, R&D (Feb.)
From:Eli Lilly & Co., Head, Platform Biology
Tel:781-891-3816
RASMUSSEN, Henrik
To:Novo Nordisk AS, VP, Clin., Medical & Reg. Affairs (Feb.)
From:Nabi Biopharmaceuticals, SVP, Clin., Research, Reg. & Medical Affairs
Tel:+45 4444 8888
SHAFFER, James P.
To:New River Pharmaceuticals Inc., VP, Sales & Mktg. (Feb.)
From:Prestwick Pharmaceuticals, Senior Dir., Commercial Operations
Tel:540-633-7978
STEIN, Jeffrey, PhD
To:Trius Therapeutics Inc., Pres. & CEO (Feb.)
From:Soffinova Ventures, Partner
Tel:858-452-0370
THIROLOIX, Stéphane
To:Ipsen, EVP, Corp. Dev. (Feb.)
From:Bristol-Myers Squibb Co., VP, Europe & General Manager, France
Tel:+33 44 30 43 43
WIBERG, Erik
To:Catalyst Biosciences Inc., CFO (Feb.)
From:Alza Corp., VP, Bus. Dev.
Tel:650-871-0761
WILLIAMSON, Kirk
To:ViaCell Inc., VP, Mktg. (Jan.)
From:The Gillette Co., VP & Gen. Manager, Oral-B Professional Products
Tel:617-914-3400
WUURMAN, Bart
To:AM-Pharma BV, CEO (Feb.)
From:DeNovo Pharmaceuticals Inc., CEO
Tel:+31 30 228 9222
Promotions
DUNCAN, Barbara
To:DOV Pharmaceutical Inc.
New Title:CEO, CFO & Treas.
Previous Title:CFO & Treas.
Tel:732-907-3600
FAUPEL, Mark L., PhD
Company:SpectRx Inc.
New Title:Pres. & COO
Previous Title:EVP, CTO
Tel:720-242-8723
GERMANO, Geno
Company:Wyeth Pharmaceuticals
New Title:Pres., US & Gen. Manager
Previous Title:EVP, Pharmaceutical Business Unit
Tel:610-902-1200
GUTTERSON, Neal
Company:Mendel Biotechnology Inc.
New Title:Pres. & CEO
Previous Title:Pres. & COO
Tel:510-264-0280
IRACE, Greg
Company:Sanofi-Aventis Group US
New Title:Pres. & CEO, US Pharmaceutical Operations
Previous Title:CFO & SVP, Fin. & Admin.
Tel:212-551-4400
KOHLER, Heinz, PhD
Company:InNexus Biotechnology Inc.
New Title:CSO
Previous Title:VP, Research
Tel:604-990-8382
MCAFEE, Don, PhD
Company:Cardiome Pharma Corp.
New Title:CSO
Previous Title:VP, Research
Tel:604-667-6905
O’CONNOR, Rita M.
Company:Adams Respiratory Therapeutics Inc.
New Title:CFO & Treas.
Previous Title:Dir., Accounting & Fin.
Tel:908-879-1400
PAIVA, Joseph M.
Company:Orthovita Inc.
New Title:Chief Bus. Officer
Previous Title:CFO
Tel:610-640-1775
PAVUCEK, Albert J., Jr.
Company:Orthovita Inc.
New Title:CFO
Previous Title:VP, Fin. & Controller
Tel:610-640-1775
PETRASS, Joerg
Company:Mologen AG
New Title:CFO
Previous Title:Deputy Managing Dir., Fin.
Tel:+49 30 84 17 88 0
POUSSOT, Bernard
Company:Wyeth
New Title:Pres, COO & Vice Chmn.
Previous Title:Pres. & Vice Chmn.
Tel:973-660-5000
SCHACHLE, Joseph K.
Company:Inspire Pharmaceuticals Inc.
New Title:EVP, Chief Commercial Operations
Previous Title:SVP, Mktg. & Sales
Tel:919-941-9777
SKOLNICK, Phil
Company:DOV Pharmaceutical Inc.
New Title:Pres. & CSO
Previous Title:CSO
Tel:732-907-3600
YERXA, Benjamin R., PhD
Company:Inspire Pharmaceuticals Inc.
New Title:CSO & EVP, Strategic Operations
Previous Title:Chief, Strategic Operations & Alliances
Tel:919-941-9777
ZAMBROWICZ, Brian P., PhD
Company:Lexicon Genetics Inc.
New Title:EVP, CSO
Previous Title:EVP, Research
Tel:281-863-3000